Submission Details
| 510(k) Number | K060709 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 16, 2006 |
| Decision Date | June 15, 2006 |
| Days to Decision | 91 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
K060709 is an FDA 510(k) clearance for the MULTIGENT GENTAMICIN, a Enzyme Immunoassay, Gentamicin (Class II — Special Controls, product code LCD), submitted by Seradyn, Inc. (Indianapolis, US). The FDA issued a Cleared decision on June 15, 2006, 91 days after receiving the submission on March 16, 2006. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3450.
| 510(k) Number | K060709 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 16, 2006 |
| Decision Date | June 15, 2006 |
| Days to Decision | 91 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
| Product Code | LCD — Enzyme Immunoassay, Gentamicin |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3450 |